Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest update is out from Pro Medicus Limited ( (AU:PME) ).
Pro Medicus Limited announced the cessation of 2,518 ordinary fully paid securities following an on-market buy-back, effective April 2, 2025. This move is part of the company’s capital management strategy, potentially impacting its share structure and market perception positively by demonstrating financial strength and shareholder value commitment.
More about Pro Medicus Limited
Pro Medicus Limited operates in the healthcare technology industry, offering advanced imaging software and services primarily for radiology departments. The company focuses on providing innovative solutions to enhance medical imaging and improve patient outcomes.
YTD Price Performance: -19.58%
Average Trading Volume: 479
Technical Sentiment Signal: Sell
Current Market Cap: $13.13B
Find detailed analytics on PME stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue